|
E2F5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.805600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.172400E-02 |
| Normal-vs-Stage2 |
8.747800E-01 |
| Normal-vs-Stage3 |
6.616000E-01 |
| Normal-vs-Stage4 |
2.573700E-02 |
| Stage1-vs-Stage2 |
3.029400E-01 |
| Stage1-vs-Stage3 |
1.499180E-01 |
| Stage1-vs-Stage4 |
1.044790E-03 |
| Stage2-vs-Stage3 |
8.768000E-01 |
| Stage2-vs-Stage4 |
7.279600E-02 |
| Stage3-vs-Stage4 |
5.706200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.321600E-01 |
| Normal-vs-AfricanAmerican |
6.650200E-01 |
| Normal-vs-Asian |
8.223800E-01 |
| Caucasian-vs-AfricanAmerican |
7.225600E-01 |
| Caucasian-vs-Asian |
9.942200E-01 |
| AfricanAmerican-vs-Asian |
9.123000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.826300E-02 |
| Normal-vs-Female |
3.223600E-01 |
| Male-vs-Female |
2.681700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.875600E-01 |
| Normal-vs-Extreme_Weight |
3.879900E-02 |
| Normal-vs-Obese |
6.135400E-01 |
| Normal-vs-Extreme_Obese |
3.197800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.038400E-01 |
| Normal_Weight-vs-Obese |
4.919800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.434000E-01 |
| Extreme_Weight-vs-Obese |
5.342000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.329800E-01 |
| Obese-vs-Extreme_Obese |
3.346000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.769700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.079000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.154360E-02 |
| Normal-vs-Age(81-100Yrs) |
2.492100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.385700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.302800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.319900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.333690E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.473600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.467600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.579200E-01 |
| Normal-VS-Type2 PRCC |
2.674600E-01 |
| Normal-VS-KIRP CIMP |
7.937200E-03 |
| Normal-VS-Unclassified PRCC |
7.285700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.718000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.76480000002588E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.928000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.74120000000699E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.730400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.85922000000005E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.321000E-03 |
| Normal-vs-N1 |
2.740500E-02 |
| Normal-vs-N2 |
4.504600E-01 |
| N0-vs-N1 |
1.039560E-03 |
| N0-vs-N2 |
3.966300E-02 |
| N1-vs-N2 |
8.308200E-01 |
|
|
